Activnutrients Without Copper And Iron Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Activnutrients Without Copper And Iron
P
- pafolacianine
- Palcaps 10 (pancrelipase)
- Pan-2400 (pancreatin)
- Panase (pancrelipase)
- Pancrease (pancrelipase)
- Pancrease MT (pancrelipase)
- Pancrease MT 10 (pancrelipase)
- Pancrease MT 16 (pancrelipase)
- Pancrease MT 20 (pancrelipase)
- Pancrease MT 4 (pancrelipase)
- Pancreatil-UL 12 (pancrelipase)
- pancreatin
- Pancreatin 4X (pancreatin)
- Pancreaze (pancrelipase)
- Pancrecarb MS (pancrelipase)
- Pancrecarb MS-16 (pancrelipase)
- Pancrecarb MS-4 (pancrelipase)
- Pancrecarb MS-8 (pancrelipase)
- pancrelipase
- Pancron D/R (pancrelipase)
- Pangestyme CN 10 (pancrelipase)
- Pangestyme CN 20 (pancrelipase)
- Pangestyme EC (pancrelipase)
- Pangestyme MT 16 (pancrelipase)
- Pangestyme UL 18 (pancrelipase)
- Pangestyme UL 20 (pancrelipase)
- Panixine (cephalexin)
- Panmycin (tetracycline)
- Panocaps (pancrelipase)
- Panocaps MT 16 (pancrelipase)
- Panokase (pancrelipase)
- Panokase 16 (pancrelipase)
- Parcopa (carbidopa / levodopa)
- patiromer
- penbutolol
- Penetrex (enoxacin)
- penicillamine
- Periostat (doxycycline)
- Pertzye (pancrelipase)
- pindolol
- Plaretase (pancrelipase)
- Plendil (felodipine)
- Posicor (mibefradil)
- Prestalia (amlodipine / perindopril)
- Prevalite (cholestyramine)
- Procardia (nifedipine)
- Procardia XL (nifedipine)
- Promacta (eltrombopag)
- propranolol
- Proquin XR (ciprofloxacin)
- Prostate SR (saw palmetto)
- Protilase (pancrelipase)
- Protilase MT-16 (pancrelipase)
- Pylera (bismuth subcitrate potassium / metronidazole / tetracycline)
More about Activnutrients Without Copper And Iron (multivitamin with minerals)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- Drug class: vitamin and mineral combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.